The Galilee Research Institute (MIGAL) spent four years creating a vaccine against the highly contagious coronavirus that infects birds called Infectious Bronchitis Virus (IBV). Now, they're adapting the vaccine for the human coronavirus, also known as COVID-19.

"Congratulations to MIGAL on this exciting breakthrough. I am confident that there will be further rapid progress, enabling us to provide a needed response to the grave global COVID-19 threat," said Israeli Minister of Science and Technology Ofir Akunis.

Akunis will fast-track the approval processes for the human coronavirus vaccine so it can hit the market as soon as possible in the form of an oral pill.

"Given the urgent global need for a human coronavirus vaccine, we are doing everything we can to accelerate development. Our goal is to produce the vaccine during the next 8-10 weeks, and to achieve safety approval in 90 days. This will be an oral vaccine, making it particularly accessible to the general public. We are currently in intensive discussions with potential partners that can help accelerate the in-human trials phase and expedite the completion final product development and regulatory activities," said MIGAL CEO David Zigdon.

Click to watch Itai Bloch, Head of Computational Chemistry and Rational Antigen Prediction Team at MIGAL Research Institute explain how they believe they could be very close to creating a vaccine to fight the coronavirus.

The poultry coronavirus is nearly identical to the human coronavirus. Israel's vaccine for the poultry coronavirus has been proven effective against the disease in pre-clinical trials carried out by the Volcani Institute.

"The scientific framework for the vaccine is based on a new protein expression vector, which forms and secretes a chimeric soluble protein that delivers the viral antigen into mucosal tissues by self-activated endocytosis (a cellular process in which substances are brought into a cell by surrounding the material with cell membrane, forming a vesicle containing the ingested material), causing the body to form antibodies against the virus. In pre-clinical (IN-VIVO) trials, MIGAL's researchers have demonstrated that the oral vaccination induces high levels of specific anti-IBV antibodies," explained Dr. Chen Katz, MIGAL's Biotechnology Group Leader.

Scientists have been scrambling to find a Coronavirus vaccine since the outbreak began infecting 83,000 people and killing more than 2,800 people.

MIGAL is working on safety approves to move ahead with preclinical testing. Subscribe for free to Breaking Christian News here

To receive daily emails from Breaking Christian News to your inbox CLICK HERE

'Young Washington' Delivers Record Opening Weekend for Angel Studios

After an Emotional Loss to Belgium, the US Men's Team Continued to Give God the Glory

A 'Miracle': CCP Releases Pastor Ezra Jin

House Speaker Johnson Braces for a High-Stakes July with Everything on the Line

Why the NATO Summit in Ankara Matters to the US

New Report Details Secret Service Failures in Butler Assassination Attempt

Charlie Kirk's Family Faces Accused Killer Tyler Robinson for the First Time as Murder Case Moves Forward

'The Passion of the Christ' Getting Theatrical Re-Release Ahead of Highly Anticipated Sequel

A Sweet Update on That Oregon Couple Who Stepped Up at the Great American State Fair

The World Lights Up for America's 250th, While the American Left Opts to Whine About It

The America 250 Celebration in DC Was One for the History Books (Videos)

Must Watch: Katharine Birbalsingh's Fiery ARC Speech-How Schools Are Destroying the Moral Core of the West (Video)

DHS Condemns Minnesota Pardon of Convicted Child Rapist

The President Rings NYSE Opening Bell from the Oval Office, While Officially Launching the Trump Accounts for Children

Venezuelan Earthquake Death Toll Soars as Country's Independence Day Arrives

July 4th Fireworks Will Be Great on America's 250th Birthday, But Your Dog Will Hate Them!

Our Favorite Patriotic Tunes, Part 2: 3 Songs Swiped from the Brits (Videos)

World Cup: Team USA Wins, Goes to the Sweet 16 Round against Belgium on Monday

3,000 Walk Boston's Freedom Trail: 'We Have A Lot to Thank God For'

Except for Democrats, a New Survey Shows Americans Still DO Have Pride in Their Country (And We Don't Mean the LGBT Kind)